Introduction:
Vivtex, a biomedical engineering startup, has partnered with pharmaceutical company Astellas to develop an oral biologic Gut-on-Chip technology. Gut-on-Chip is a platform that mimics the structure and function of the human intestine, allowing for testing and development of oral biologic drugs.
- Vivtex and Astellas have partnered to develop an oral biologic Gut-on-Chip technology.
- Gut-on-Chip is a platform that mimics the human intestine and can be used for testing and development of oral biologic drugs.
- The partnership aims to improve the efficiency and effectiveness of drug development, particularly for oral biologics.
- Gut-on-Chip technology has the potential to reduce the need for animal testing and provide more reliable results.
- The partnership between Vivtex and Astellas could lead to advancements in oral biologic drug development and improve patient outcomes.
Conclusion:
Vivtex and Astellas are collaborating to develop an oral biologic Gut-on-Chip technology, which has the potential to revolutionize drug development for oral biologics. This technology could improve the efficiency and reliability of drug testing, reduce the need for animal testing, and ultimately lead to better patient outcomes. The partnership between Vivtex and Astellas represents an important step forward in the field of biotechnology and has the potential to drive advancements in oral biologic drug development.
